NCT06903546RecruitingPhase 4
The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients
The Effect of Propolis Administration on Low Density Lipoprotein and High Density Lipoprotein in Diabetic Type 2 Patients in Central Jakarta
Source: ClinicalTrials.gov · Last updated 3 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this clinical trial is to learn if propolis administration works to change the level of Low Density Lipoprotein (LDL) and High Density Lipoprotein cholesterol (HDL) in diabetic type 2 patients. The main questions it aims to answer are: \- Is giving 1 drops/ 10kg/ times, twice daily for 8 weeks will change the level of LDL and HDL level in diabetic type 2 patients compared to placebo? Researchers will compare propolis to a placebo (a look-alike substance that contains no drug) to see if propolis works to change LDL and HDL cholesterol level. Participants will: * Take propolis or a placebo, 2 times daily with given dose (1 drops/10 kg/times) every day for 2 months * Visit the sub-district health centre once every 2 weeks for checkups * Get their blood checked before and after intervention
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 64 (estimated)
- First submitted
- 28 Mar 2025
- Start date
- 18 Mar 2025
- Primary completion date
- 30 Jun 2025
- Lead sponsor
- Universitas Indonesia
- Diseases
- Type 2 diabetes
- NCT number
- NCT06903546
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 64
- From 18 Mar 2025 to the primary completion date, 30 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Using injection therapy (insulin or GLP-1 RA)
Other illness
- History of bees product allergy
- History of cardiovascular disease (heart attack, stroke)
Lab values
- Altered liver (ALT\>35 IU/L) and kidney (eGFR\<90 mL/min) function
Other
- Active smoker
- Consuming alcohol
- Pregnant and breastfeeding women
Who the study is looking for
- Controlled Diabetes Mellitus type 2 with HbA1c \<7.5%
- BMI 23-35 kg/m2
- On anti-cholesterol therapy
Age in the registry: 35 years to 59 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Indonesia Faculty of Biomedical Science Coordinator of this site? Confirm its status | Jakarta | Indonesia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.